Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A reconstitution calculator helps verify your math before committing
FDA Warning About Compounded Ozempic Novo Nordisk, the only FDA-approved manufacturer of semaglutide, does not sell the active ingredient to compounding pharmacies
Bowen says these are great medications, but patients should stay vigilant
Who May Want to Review Novi's Program Details Based on verified information from Novi's published materials, here's an honest picture of who this program may be relevant for - and where additional caution makes sense before proceeding
According to the FDA-approved prescribing information for Wegovy (semaglutide, current label on file with the FDA as of 2026) and Zepbound (tirzepatide, current label on file with the FDA as of 2026), both carry these warnings: A boxed warning - the FDA's most serious warning category - for thyroid C-cell tumors observed in rodent studies
